Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bortezomib and celecoxib may stop the growth of tumor cells by blocking some of
the enzymes needed for cell growth. Giving bortezomib together with celecoxib may kill more
tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of bortezomib and
celecoxib in treating patients with advanced solid tumors.